S
Stockadora

Recent Material Events

Track the latest material events (8-K filings) with AI-powered analysis. Stay informed about major corporate developments, acquisitions, and changes.

📊 1045 Events
🤖 AI Analyzed
Recent
📄 Page 56 of 88
TIC Solutions, Inc.
8-K March 12, 2026

Key Highlights

  • Strong financial results for Q4 and full fiscal year 2025, meeting or exceeding ...
  • Planned CEO succession with experienced internal leader Benjamin Heraud, who pre...
  • Outgoing CEO Talman Pizzey ensures continuity by remaining as a consultant until...
Read Analysis
🤖 AI Generated
Karman Holdings Inc.
8-K March 12, 2026

Key Highlights

  • Jonathan Rambeau appointed as the new CEO, signaling a potential strategic shift...
  • Mr. Rambeau's background could lead the company to lean more towards areas like ...
  • New leadership often brings fresh priorities and approaches, potentially creatin...
Read Analysis
🤖 AI Generated
OMNICOM GROUP INC.
8-K March 12, 2026

Key Highlights

  • Targets approximately 4% organic revenue growth for 2026, reflecting confidence ...
  • Aims for $1.5 billion in cost savings (synergies) over 30 months, with $900 mill...
  • Forecasts double-digit growth in adjusted net income per share, indicating enhan...
Read Analysis
🤖 AI Generated
STRYKER CORP
8-K March 12, 2026

Key Highlights

  • Stryker Corp (SYK) announced a major global cybersecurity incident.
  • The incident, identified March 11, 2026, has significantly disrupted global oper...
  • Stryker cannot currently estimate the duration of the disruption or its full fin...
Read Analysis
🤖 AI Generated
NON INVASIVE MONITORING SYSTEMS INC /FL/
8-K March 12, 2026

Key Highlights

  • NIMS is undergoing a reverse merger with Gravitics, a privately-held space techn...
  • The combined entity will pivot entirely to Gravitics's innovative space business...
  • This represents a complete business transformation from a dormant medical monito...
Read Analysis
🤖 AI Generated
ADOBE INC.
8-K March 12, 2026

Key Highlights

  • Adobe's Q1 FY2026 financials beat expectations with strong revenue and EPS growt...
  • Total Revenue hit $5.35 billion (up 12% YoY), Non-GAAP EPS $4.48 (up 15% YoY).
  • CEO Shantanu Narayen transitions to Chairman, ensuring leadership continuity.
Read Analysis
🤖 AI Generated
BLUE RIDGE BANKSHARES, INC.
8-K March 12, 2026

Key Highlights

  • G. William Beale has retired as President and CEO, effective March 6, 2026.
  • Harry Golliday, former Chief Credit Officer, has been appointed Interim Presiden...
  • The transition is described as planned and amicable, with a comprehensive search...
Read Analysis
🤖 AI Generated
CRYO CELL INTERNATIONAL INC
8-K March 12, 2026

Key Highlights

  • Cryo-Cell International (CCEL) is a leader and pioneer in cord blood banking.
  • The company has received a formal notice from NYSE American regarding non-compli...
  • There is a potential for recovery and investor confidence if compliance is regai...
Read Analysis
🤖 AI Generated
SAGA COMMUNICATIONS INC
8-K March 12, 2026

Key Highlights

  • SAGA COMMUNICATIONS INC exceeded Q4 2025 revenue and net income analyst expectat...
  • Reported strong Q4 2025 revenue of $25.5 million (2% YoY increase) and net incom...
  • Full-year 2025 revenue reached $101.2 million (1% YoY increase) and net income $...
Read Analysis
🤖 AI Generated
Theriva Biologics, Inc.
8-K March 12, 2026

Key Highlights

  • Promising clinical and regulatory progress for lead drug candidate VCN-01.
  • Strategic SYN-020 licensing deal provides non-dilutive funding and sharpens focu...
  • Net loss improved to $23.7 million in 2025 from $25.6 million in 2024.
Read Analysis
🤖 AI Generated
Innovex International, Inc.
8-K March 11, 2026

Key Highlights

  • Innovex's subsidiary, Downhole Well Solutions, LLC (DWS), was found liable for w...
  • A jury awarded $47.6 million in damages, with the potential for this amount to b...
  • Innovex strongly disputes the verdict and plans to vigorously appeal the decisio...
Read Analysis
🤖 AI Generated
Vistagen Therapeutics, Inc.
8-K March 11, 2026

Key Highlights

  • Extended Cash Runway: Funding operations into 2027, easing immediate financial p...
  • Sharpened Focus on Fasedienol: Prioritizing the lead drug candidate for acute so...
  • Strategic Realignment: Calculated step to save capital and streamline operations...
Read Analysis
🤖 AI Generated

Stay Informed with AI Analysis

Get comprehensive insights from material event filings with our AI-powered analysis. Track corporate developments, acquisitions, and strategic changes.

Back to Homepage